SCIENTURE HOLDINGS, INC. Convertible Notes Payable, Current
SCIENTURE HOLDINGS, INC. (SCNX) had Convertible Notes Payable, Current of $2.00 million as of 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes and Loans Payable, Current › Notes Payable, Current
us-gaap:ConvertibleNotesPayableCurrent · last filed 2026-03-30
- 2025-09-30: Convertible Notes Payable, Current $2.00M.
- 2025-06-30: Convertible Notes Payable, Current $2.00M.
- 2025-03-31: Convertible Notes Payable, Current $2.00M.
- 2024-12-31: Convertible Notes Payable, Current $2.29M.
| Period end | Convertible Notes Payable, Current | Convertible Notes Payable, Current as first filed |
|---|---|---|
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $2.00M 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $2.29M 10-K · filed 2026-03-30 | |
| 2020-12-31 | $0.00 10-K · filed 2021-03-29 | |
| 2019-12-31 | $0.00 10-K · filed 2021-03-29 | |
| 2018-12-31 | $181.50K 10-K · filed 2020-03-30 | |
| 2017-12-31 | $0.00 10-K · filed 2018-03-02 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-07 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $229.73K 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $165.00K 10-K · filed 2018-03-02 | $203.38K 10-K · filed 2017-03-30 |
| 2016-09-30 | $285.43K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $165.00K 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $729.38K 10-Q · filed 2016-04-20 | |
| 2015-12-31 | $0.00 10-K · filed 2017-03-30 | $708.39K 10-K · filed 2016-03-28 |
| 2015-09-30 | $137.53K 10-Q · filed 2015-11-02 | |
| 2015-06-30 | $110.76K 10-Q · filed 2015-07-30 | |
| 2014-12-31 | $0.00 10-K · filed 2016-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |